Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
Gurjar MK, Wakharkar RD, Singh AT, Jaggi M, Borate HB, Shinde PD, Verma R, Rajendran P, Dutt S, Singh G, Sanna VK, Singh MK, Srivastava SK, Mahajan VA, Jadhav VH, Dutta K, Krishnan K, Chaudhary A, Agarwal SK, Mukherjee R, Burman AC.
Gurjar MK, et al. Among authors: jaggi m.
J Med Chem. 2007 Apr 19;50(8):1744-53. doi: 10.1021/jm060938o. Epub 2007 Mar 21.
J Med Chem. 2007.
PMID: 17373779